Business
Currency:USD
2024/FY
Stock NameRevenueRatio
Providing advanced cancer genomic tests for precision oncology and personalized testing84.61M100.00%
Region
Currency:USD
2024/FY
Stock NameRevenueRatio
United States81.23M96.00%
Others3.38M4.00%